Xiaotong Hou
Clinical trials sponsored by Xiaotong Hou, explained in plain language.
-
Could a new blood thinner make ECMO safer after heart surgery?
Disease control Recruiting nowThis study compares a drug called nafamostat mesilate to the standard blood thinner heparin in 80 adults who need a heart-lung machine (ECMO) after heart surgery. The goal is to see if nafamostat can prevent dangerous blood clots while causing fewer bleeding problems. Participant…
Phase: NA • Sponsor: Xiaotong Hou • Aim: Disease control
Last updated May 17, 2026 05:22 UTC
-
New blood thinner tested for critical Heart-Lung machine patients
Disease control Recruiting nowThis study compares two blood-thinning medications (bivalirudin and heparin) in adults who need a heart-lung bypass machine (ECMO). Researchers want to see which drug works better to prevent dangerous blood clots while causing fewer bleeding problems. The goal is to find the safe…
Phase: NA • Sponsor: Xiaotong Hou • Aim: Disease control
Last updated Apr 16, 2026 13:01 UTC